Mia's Feed
Medical News & Research

Underutilization of Medications for Alcohol Use Disorder in Emergency Departments Highlights Opportunities for Improved Care

Underutilization of Medications for Alcohol Use Disorder in Emergency Departments Highlights Opportunities for Improved Care

Share this article

Emergency departments often miss opportunities to treat alcohol use disorder, with less than 1% of high-risk patients receiving prescribed medications. Increasing clinician awareness could improve outcomes for individuals with AUD.

2 min read

Recent research indicates that emergency departments are missing significant opportunities to identify and treat individuals with alcohol use disorder (AUD). A study published in Alcohol, Clinical and Experimental Research analyzed electronic health records from 12 hospitals over a two-year period and found that less than 1% of patients who screened positive for high-risk drinking received a prescription for medication to address AUD. Notably, more than half of those prescribed medications filled their prescriptions, suggesting that increasing awareness and training among emergency clinicians could enhance treatment rates.

The study examined over fifty thousand emergency visits where patients with hazardous drinking patterns were treated and discharged. It was observed that prescriptions for naltrexone, an effective medication to reduce alcohol cravings and support recovery, were issued in only about 0.5% of cases. Patients more likely to receive a prescription tended to be younger, male, non-Hispanic, and those with more severe alcohol misuse. Additionally, individuals presenting with alcohol-related issues or diagnosed with alcohol withdrawal were more likely to be prescribed naltrexone. Interestingly, the type of insurance or a history of mental illness did not significantly influence prescribing patterns.

The researchers emphasize that screening for alcohol use disorder in the emergency setting is a crucial initial step. Follow-up interventions like brief counseling and referrals to behavioral health services are essential for encouraging ongoing treatment and recovery. Given that alcohol-related visits have increased nearly 50% over the past decade, and that nearly 10% of these patients die within a year of their first episode, emergency departments remain a critical point of intervention. Addressing the current gap in medication prescribing can significantly impact patient outcomes and reduce the public health burden of AUD.

In conclusion, enhancing clinician education about the benefits of medications like naltrexone, along with systematic screening and intervention protocols, could greatly improve the management of alcohol use disorder in emergency care settings.

Source: https://medicalxpress.com/news/2025-09-limited-medications-alcohol-disorder-emergency.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Breakthrough 'Molecular Light Switch' Promises Restored Sight, Hearing, and Heart Function

A newly developed light-sensitive protein, ChReef, advances optogenetic therapy, offering promising treatment options for sight, hearing, and heart rhythm restoration with low light doses, paving the way for innovative medical applications.

Cerebroplacental Ratio Enhances Delivery Decisions in cases of Perceived Reduced Fetal Movement

A new study shows that assessing the cerebroplacental ratio during ultrasound can improve decision-making for labor in pregnancies with perceived reduced fetal movement, leading to better outcomes.

Revolutionary AI Tool Accelerates Medical Image Segmentation for Clinical Research

MIT researchers have unveiled an AI-powered tool that dramatically speeds up the process of annotating and segmenting medical images, promising to transform clinical research and diagnostics with faster, more efficient workflows.

Innovative Approach Uses Neutrophil Reprogramming to Combat Breast Cancer

A new study highlights how retraining neutrophils via innate immunity activation offers a promising therapeutic approach for difficult-to-treat breast cancers, including triple-negative subtypes.